Archive (english)

This is a translation of the table of contents. One article of each issue is translated and freely available.

table of contents

NEW ON THE MARKET

Antiarrhythmic drug dronedarone (MULTAQ) for atrial fibrillation

REVIEW

Fat-modified diet for cardiovascular prevention - what is proven?

IN BRIEF

UMCKALOABO - patent for manufacturing revoked

Inhibitor ranibizumab (LUCENTIS): erratum

SIDE EFFECTS

Finally: appetite suppressant sibutramine (REDUCTIL) off market
free

Progressive multifocal leukencephalopathy (PML) due to natalizumab (TYSABRI)

Independent drug information – in English

Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

Browse free articles